Asia Pacific Apac Radiotherapy Market
시장 규모 (USD 10억)
연평균 성장률 :
% 
 예측 기간 |
2023 –2030 |
 시장 규모(기준 연도) |
USD 1,595.61 Million |
 시장 규모(예측 연도) |
USD 3,321.79 Million |
 연평균 성장률 |
% |
| 주요 시장 플레이어 |
|
>아시아 태평양 방사선 치료 시장, 제품 및 서비스별(서비스, 제품 및 소프트웨어), 유형(외부 빔 방사선 치료, 내부 방사선 치료, 전신 방사선 치료/ 방사성 의약품 및 기타), 응용 분야(유방암, 폐암, 전립선암, 대장암, 림프종, 간암, 갑상선암, 뇌암, 자궁경부암, 척추암 및 기타), 최종 사용자(병원, 방사선 치료 센터, 전문 클리닉 및 기타), 유통 채널(직접 입찰, 제3자 유통업체 및 기타) - 업계 동향 및 2030년까지의 예측.
아시아 태평양 방사선 치료 시장 분석 및 규모
아시아 태평양 지역의 암 발병률은 증가하고 있으며, 방사선 요법은 많은 암 유형에 대한 중요한 치료 방식입니다. 인구가 계속 고령화되고 라이프스타일이 변화함에 따라 암 사례 수가 증가할 것으로 예상되어 방사선 요법에 대한 수요가 증가할 것입니다. 암과 치료 옵션에 대한 인식이 높아지고, 스크리닝 및 조기 발견 방법이 개선됨에 따라 방사선 요법을 포함한 암 치료를 찾는 사람이 늘어났습니다. 많은 국가에서 의료비 지출이 증가하여 방사선 요법과 같은 고급 치료에 대한 자금이 더 많이 지원되었습니다. 정부와 민간 의료 서비스 제공자는 시설과 장비를 업그레이드하는 데 투자해 왔습니다.
Data Bridge Market Research는 아시아 태평양 방사선 치료 시장이 2022년 1,595.61백만 달러에서 2030년까지 3,321.79백만 달러 규모로 성장할 것으로 예상하며, 예측 기간 동안 CAGR 10.0%로 성장할 것으로 분석했습니다. 이 시장 보고서는 또한 가격 분석과 기술 발전에 대한 심층적인 내용을 다룹니다.
|
보고서 메트릭 |
세부 |
|
예측 기간 |
2023년부터 2030년까지 |
|
기준 연도 |
2022 |
|
역사적 연도 |
2021 (2015-2020까지 사용자 정의 가능) |
|
양적 단위 |
매출은 백만 달러, 볼륨은 단위, 가격은 달러로 표시됨 |
|
다루는 세그먼트 |
제품 및 서비스(서비스, 제품 및 소프트웨어), 유형(외부 빔 방사선 치료, 내부 방사선 치료, 전신 방사선 치료/방사성 의약품 및 기타), 응용 분야(유방암, 폐암, 전립선암, 대장암, 림프종, 간암, 갑상선암, 뇌암, 자궁경부암, 척추암 및 기타), 최종 사용자(병원, 방사선 치료 센터, 전문 병원 및 기타), 유통 채널(직접 입찰, 제3자 유통업체 및 기타) |
|
적용 국가 |
중국, 일본, 호주, 인도, 한국, 뉴질랜드, 싱가포르, 태국, 말레이시아, 베트남, 대만, 인도네시아, 필리핀, 그리고 아시아 태평양의 나머지 지역입니다. |
|
시장 참여자 포함 |
Siemens Healthcare GmbH, Elekta, General Electric Company, Hitachi, Ltd., Koninklijke Philips NV, Zeiss International, IBA Worldwide, CANON MEDICAL SYSTEMS CORPORATION, Accuray Incorporated, Mevion medical System, Brainlab AG, Eckert & Ziegler BEBIG, VIEWRAY TECHNOLOGIES, INC.(“VIEWRAY”) 및 Nordion Inc.(Sotera Health의 자회사) 등이 있습니다. |
시장 정의
Radiotherapy is a type of treatment procedure that is mainly used for the treatment of cancer disease by the usage of X-rays along with similar forms of radiation technology. In radiotherapy treatment, high-energy-based radiation rays are often used to damage cancer cells and stop them from growing and dividing. Various types of software such as treatment planning software, dosage planning software, patient positioning software, image guiding software, and systemic radiotherapy among others are used in radiotherapy treatment planning. The treatment software program is used to calculate the dose of radiation that will be delivered to the patient's tumor and the surrounding normal tissue.
Asia-Pacific Radiotherapy Market Dynamics
This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
- Growing Prevalence of Cancer Disease
The Asia-Pacific incidence of cancer continues to rise due to factors such as aging populations, lifestyle changes, environmental factors, and increased cancer awareness and screening. The demand for effective treatment options such as radiotherapy grows as more individuals are diagnosed with cancer. Radiotherapy can be used as a primary treatment for cancer, especially in cases where surgery is not feasible or as effective. It can also be used in conjunction with surgery, chemotherapy, or immunotherapy to enhance treatment outcomes. The versatility of radiotherapy makes it an essential tool in the comprehensive cancer treatment arsenal.
Cancer disease has a major impact Asia-Pacificly. Statistics on cancer describe that large groups of people have cancer across the world. Statistics show things that many people died from cancer each year. The treatment of radiotherapy can cure cancer symptoms. Radiation therapy uses high-energy particles or waves to kill the symptoms of cancer. Several people who are currently living with cancer require radiotherapy for cancer treatment. For this reason, the growing prevalence of cancer disease is acting as a driver for increasing the demand for the market.
- Novel Technology in Radiotherapy for Cancer Treatment
During the past several years, cancer radiotherapy has been largely driven by technological development. The technological development in radiotherapy is mainly focused on improving therapy procedures and launching new products which have advanced features that help in the treatment of cancer patients. This special issue aims at novel technological developments and has large potential in improving patient safety and treatment outcome in the radiotherapy management of cancers worldwide.
The modern and advanced technology-based radiotherapy procedure comprises the use of three-dimensional (3D) imaging technology, high-energy x-ray machines, and computerized treatment planning, which enhances the chances for more precise treatment. The increasing number of patients who successfully use radiation therapy due to technological advancement in radiotherapy and novel technology in radiotherapy for cancer treatment is expected to drive market growth.
Opportunity
- Increasing Healthcare Expenditure for Cancer Treatment
The government is continuously engaged in the activity of improving healthcare facilities to provide better health facilities and treatment to the patients such as improving cancer treatment procedures and increasing the number of radiotherapy treatment providers, among others. Growing healthcare expenditure is an opportunity for the market, because if investment in healthcare increases more people are getting aware of cancer disease and undergo advanced technology-based cancer treatment.
Continuously increasing healthcare expenditure helps the end user to install the latest technology-based radiotherapy systems to improve efficiency, accuracy, and number of successful radiotherapy cancer treatments.
Hence, the increasing healthcare expenditure for cancer treatment is expected to create an opportunity for market growth.
Restraint / Challenge
- Lack of Skilled and Certified Professionals
Radiotherapy is a type of complex procedure, operated by highly advanced radiotherapy products which deliver radiation explorer to a targeted point of the patient body to destroy the cancer cells. The radiotherapy procedure requires highly skilled and certified professionals as in this procedure, healthcare professionals have to decide the dosages of radiation delivered to the patient's body with the help of treatment planning software. Healthcare professionals need to be aware of how to handle these software and therapy modalities. The requirement for skilled and certified professionals is a big restraint for the market. The demand for cancer treatment is increasing due to continuously increasing cases of cancer disease across the world but a lack of skilled and certified professionals hampering the growth of the market.
The requirement for trained staff is a big issue for the radiotherapy market, due to which the lack of skilled and certified professionals, end users are not able to install advanced products of radiotherapy procedures, the reason, lack of skilled and certified professionals are expected to restrain market growth.
Asia-Pacific Radiotherapy Market Scope
아시아 태평양 방사선 치료 시장은 제품 및 서비스, 유형, 응용 프로그램, 최종 사용자 및 유통 채널을 기준으로 하는 5가지 주요 세그먼트로 분류됩니다. 이러한 세그먼트 간의 성장은 산업의 빈약한 성장 세그먼트를 분석하고 사용자에게 핵심 시장 응용 프로그램을 식별하기 위한 전략적 결정을 내리는 데 도움이 되는 귀중한 시장 개요와 시장 통찰력을 제공하는 데 도움이 됩니다.
제품 및 서비스
- 서비스
- 제품
- 소프트웨어
제품은 물론 서비스를 기준으로 시장은 서비스, 제품, 소프트웨어로 세분화됩니다.
유형
- 외부 빔 방사선 치료
- 내부 방사선 치료
- 전신방사선치료/방사성의약품
- 기타
시장은 유형을 기준으로 외부 방사선 치료, 내부 방사선 치료, 전신 방사선 치료/방사성 의약품 및 기타로 구분됩니다.
애플리케이션
- 유방암
- 폐암
- 전립선암
- 대장암
- 림프종
- 간암
- 갑상선 암
- 뇌암
- 자궁경부암
- 척추암
- 기타
시장은 응용 프로그램을 기준으로 유방암, 폐암, 전립선암, 대장암, 림프종, 간암, 갑상선암, 뇌암, 자궁경부암, 척추암 등으로 구분됩니다.
최종 사용자
- 병원
- 방사선 치료 센터
- 전문 클리닉
- 기타
최종 사용자를 기준으로 시장은 병원, 방사선 치료 센터, 전문 병원 등으로 구분됩니다.
유통 채널
- 직접 입찰
- 제3자 유통업체
- 기타
유통 채널을 기준으로 시장은 직접 입찰, 제3자 유통업체 및 기타로 구분됩니다 .
아시아 태평양 방사선 치료 시장 지역 분석/통찰력
위에 언급된 대로, 아시아 태평양 방사선 치료 시장을 분석하고, 국가, 제품 및 서비스, 유형, 응용 분야, 최종 사용자, 유통 채널별로 시장 규모에 대한 통찰력과 추세를 제공합니다.
이 시장 보고서에서 다루는 국가는 중국, 일본, 호주, 인도, 한국, 뉴질랜드, 싱가포르, 태국, 말레이시아, 베트남, 대만, 인도네시아, 필리핀, 그리고 아시아 태평양의 나머지 지역입니다.
중국은 의료 시스템의 발전과 다양한 유형의 암 유병률 증가, 가장 많은 환자 수를 보유하고 있어 가장 큰 시장 점유율을 차지하며 시장을 장악할 것으로 예상됩니다.
보고서의 국가 섹션은 또한 현재 및 미래 시장 추세에 영향을 미치는 개별 시장 영향 요인과 시장 규제의 변화를 제공합니다. 하류 및 상류 가치 사슬 분석, 기술 추세, 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 아시아 태평양 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세의 영향 및 무역 경로가 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.
경쟁 환경 및 아시아 태평양 방사선 치료 시장 점유율 분석
아시아 태평양 방사선 치료 시장 경쟁 구도는 경쟁자에 대한 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 새로운 시장 이니셔티브, 아시아 태평양 지역 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 제공된 위의 데이터 포인트는 시장과 관련된 회사의 초점에만 관련이 있습니다.
아시아 태평양 방사선 치료 시장에서 활동하는 주요 기업으로는 Siemens Healthcare GmbH, Elekta, General Electric Company, Hitachi, Ltd., Koninklijke Philips NV, Zeiss International, IBA Worldwide, CANON MEDICAL SYSTEMS CORPORATION, Accuray Incorporated, Mevion medical Systems, Brainlab AG, Eckert & Ziegler BEBIG, VIEWRAY TECHNOLOGIES, INC.(“VIEWRAY), NordionInc.(Sotera Health의 자회사) 등이 있습니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE ASIA-PACIFIC RADIOTHERAPY MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT AND SERVICES SEGMENT LIFELINE CURVE
2.8 MARKET END USERS COVERAGE GRID
2.9 DBMR MARKET POSITION GRID
2.1 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTLE ANALYSIS
4.2 PORTER'S FIVE FORCES MODEL
5 REGULATORY GUIDELINES FOR RADIOTHERAPY
5.1 INDIA REGULATORY GUIDELINE FOR RADIOTHERAPY
5.2 CHINA REGULATORY GUIDELINE FOR RADIOTHERAPY
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 GROWING PREVALENCE OF CANCER DISEASE
6.1.2 NOVEL TECHNOLOGY IN RADIOTHERAPY FOR CANCER TREATMEN
6.1.3 INCREASING ADOPTION OF RADIOTHERAPY DEVICES AND PROCEDURES
6.1.4 RISING PREFERENCE FOR NON-SURGICAL PROCEDURES
6.2 RESTRAINTS
6.2.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS
6.2.2 HIGH COST OF TREATMENT AND RADIOTHERAPY PROCEDURE
6.3 OPPORTUNITIES
6.3.1 INCREASING HEALTHCARE EXPENDITURE FOR CANCER TREATMENT
6.3.2 GROWING GOVERNMENT INITIATIVES TOWARD CANCER TREATMENT
6.3.3 RISING PATIENTS AWARENESS TOWARDS CANCER TREATMENT
6.4 CHALLENGES
6.4.1 STRICT REGULATIONS AND STANDARDS FOR APPROVAL AND COMMERCIALIZATION OF RADIOTHERAPY PRODUCTS
6.4.2 RISK OF RADIATION EXPOSURE
7 ASIA-PACIFIC RADIOTHERAPY MARKET, BY PRODUCT & SERVICES
7.1 OVERVIEW
7.2 SERVICES
7.3 PRODUCT
7.3.1 EXTERNAL BEAM RADIOTHERAPY
7.3.1.1 LINAC
7.3.1.2 PROTON THERAPY
7.3.1.2.1 SYNCHROTRON
7.3.1.2.2 CYCLOTRON
7.3.1.3 CYBER KNIFE
7.3.1.4 GAMMA KNIFE
7.3.1.5 OTHERS
7.3.2 INTERNAL RADIATION RADIOTHERAPY
7.3.2.1 SEEDS
7.3.2.2 ELECTRONIC BRACHYTHERAPY
7.3.2.3 APPLICATORS
7.3.2.4 AFTERLOADERS
7.3.2.5 OTHERS
7.3.3 SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS
7.3.3.1 ALPHA EMITTERS
7.3.3.2 BETA EMITTERS
7.3.3.3 OTHERS
7.4 SOFTWARE
7.4.1 IMAGE GUIDING SOFTWARE
7.4.2 TREATMENT PLANNING SOFTWARE
7.4.3 PATIENT POSITIONING SOFTWARE
7.4.4 DOSAGE PLANNING SOFTWARE
7.4.5 OTHERS
8 ASIA-PACIFIC RADIOTHERAPY MARKET, BY TYPE
8.1 OVERVIEW
8.2 EXTERNAL-BEAM RADIATION THERAPY
8.2.1 IMAGE-GUIDED RADIATION THERAPY (IGRT)
8.2.2 PROTON BEAM THERAPY
8.2.3 STEREOTACTIC RADIATION THERAPY
8.2.4 INTENSITY MODULATED RADIATION THERAPY (IMRT)
8.2.5 THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY (3D-CRT)
8.2.6 VOLUMETRIC MODULATED ARC THERAPY (VMAT)
8.2.7 OTHERS
8.3 INTERNAL RADIATION THERAPY
8.3.1 BRACHYTHERAPY
8.3.2 INTRAOPERATIVE RADIATION THERAPY (IORT)
8.3.3 OTHERS
8.4 SYSTEMIC RADIOTHERAPY/ RADIOPHARMACEUTICALS
8.5 OTHERS
9 ASIA-PACIFIC RADIOTHERAPY MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 BREAST CANCER
9.3 LUNG CANCER
9.4 PROSTATE CANCER
9.5 COLORECTAL CANCER
9.6 LYMPHOMA
9.7 LIVER CANCER
9.8 THYROID CANCER
9.9 BRAIN CANCER
9.1 CERVICAL CANCER
9.11 SPINE CANCER
9.12 OTHERS
10 ASIA-PACIFIC RADIOTHERAPY MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.3 RADIATION THERAPY CENTERS
10.4 SPECIALTY CLINICS
10.5 OTHERS
11 ASIA-PACIFIC RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDERS
11.3 THIRD PARTY DISTRIBUTORS
11.4 OTHERS
12 ASIA-PACIFIC RADIOTHERAPY MARKET, BY GEOGRAPHY
12.1 ASIA-PACIFIC
12.1.1 CHINA
12.1.2 JAPAN
12.1.3 AUSTRALIA
12.1.4 INDIA
12.1.5 SOUTH KOREA
12.1.6 NEW ZEALAND
12.1.7 SINGAPORE
12.1.8 THAILAND
12.1.9 MALAYSIA
12.1.10 VIETNAM
12.1.11 TAIWAN
12.1.12 INDONESIA
12.1.13 PHILIPPINES
12.1.14 REST OF ASIA-PACIFIC
13 ASIA-PACIFIC RADIOTHERAPY MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
14 SWOT ANALYSIS
15 COMPANY PROFILES
15.1 ELEKTA
15.1.1 COMPANY SNAPSHOT
15.2 REVENUE ANALYSIS
15.2.1 PRODUCT PORTFOLIO
15.2.2 RECENT DEVELOPMENTS
15.3 GENERAL ELECTRIC COMPANY
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 PRODUCT PORTFOLIO
15.3.4 RECENT DEVELOPMENT
15.4 CANON MEDICAL SYSTEMS CORPORATION
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 PRODUCT PORTFOLIO
15.4.4 RECENT DEVELOPMENT
15.5 HITACHI, LTD.
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 PRODUCT PORTFOLIO
15.5.4 RECENT DEVELOPMENT
15.6 SIEMENS HEALTHCARE GMBH
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENT
15.7 ACCURACY INCORPORATED
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 RECENT DEVELOPMENT
15.8 BEBIG MEDICAL.
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENT
15.9 BRAINLAB
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT DEVELOPMENTS
15.1 ECKERT & ZIEGLER BEBIG
15.10.1 COMPANY SNAPSHOT
15.10.2 REVENUE ANALYSIS
15.10.3 PRODUCT PORTFOLIO
15.10.4 RECENT DEVELOPMENT
15.11 IBA WORLDWIDE
15.11.1 COMPANY SNAPSHOT
15.11.2 REVENUE ANALYSIS
15.11.3 PRODUCT PORTFOLIO
15.11.4 RECENT DEVELOPMENT
15.12 KONINKLIJKE PHILIPS N.V.
15.12.1 COMPANY SNAPSHOT
15.12.2 REVENUE ANALYSIS
15.12.3 PRODUCT PORTFOLIO
15.12.4 RECENT DEVELOPMENT
15.13 LINATECH INC
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENT
15.14 MEVION MEDICAL SYSTEMS
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENT
15.15 NORDION (CANADA) INC. (A SUBSIDIARY OF SOTERA HEALTH)
15.15.1 COMPANY SNAPSHOT
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENT
15.16 SHINVA MEDICAL INSTRUMENT CO., LTD.
15.16.1 COMPANY SNAPSHOT
15.16.2 PRODUCT PORTFOLIO
15.16.3 RECENT DEVELOPMENT
15.17 UNITED IMAGING HEALTHCARE CO., LTD
15.17.1 COMPANY SNAPSHOT
15.17.2 PRODUCT PORTFOLIO
15.17.3 RECENT DEVELOPMENT
15.18 VIEWRAY TECHNOLOGIES, INC. (“VIEWRAY”)
15.18.1 COMPANY SNAPSHOT
15.18.2 REVENUE ANALYSIS
15.18.3 PRODUCT PORTFOLIO
15.18.4 RECENT DEVELOPMENT
15.19 ZEISS INTERNATIONAL
15.19.1 COMPANY SNAPSHOT
15.19.2 REVENUE ANALYSIS
15.19.3 PRODUCT PORTFOLIO
15.19.4 RECENT DEVELOPMENT
16 QUESTIONNAIRE
17 RELATED REPORTS
표 목록
TABLE 1 ASIA-PACIFIC RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 2 ASIA-PACIFIC PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 3 ASIA-PACIFIC EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 4 ASIA-PACIFIC PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 5 ASIA-PACIFIC INTERNAL RADIATION RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 6 ASIA-PACIFIC SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 7 ASIA-PACIFIC SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 8 ASIA-PACIFIC RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 9 ASIA-PACIFIC EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 10 ASIA-PACIFIC INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 11 ASIA-PACIFIC RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 12 ASIA-PACIFIC RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 13 ASIA-PACIFIC RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 14 ASIA-PACIFIC RADIOTHERAPY MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 15 CHINA RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 16 CHINA PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 17 CHINA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 18 CHINA PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 19 CHINA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 20 CHINA SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 21 CHINA SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 22 CHINA RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 23 CHINA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 24 CHINA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 25 CHINA RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 26 CHINA RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 27 CHINA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 28 JAPAN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 29 JAPAN PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 30 JAPAN EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 31 JAPAN PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 32 JAPAN INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 33 JAPAN SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 34 JAPAN SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 35 JAPAN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 36 JAPAN EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 37 JAPAN INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 38 JAPAN RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 39 JAPAN RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 40 JAPAN RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 41 AUSTRALIA RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 42 AUSTRALIA PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 43 AUSTRALIA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 44 AUSTRALIA PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 45 AUSTRALIA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 46 AUSTRALIA SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 47 AUSTRALIA SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 48 AUSTRALIA RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 49 AUSTRALIA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 50 AUSTRALIA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 51 AUSTRALIA RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 52 AUSTRALIA RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 53 AUSTRALIA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 54 INDIA RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 55 INDIA PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 56 INDIA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 57 INDIA PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 58 INDIA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 59 INDIA SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 60 INDIA SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 61 INDIA RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 62 INDIA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 63 INDIA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 64 INDIA RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 65 INDIA RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 66 INDIA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 67 SOUTH KOREA RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 68 SOUTH KOREA PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 69 SOUTH KOREA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 70 SOUTH KOREA PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 71 SOUTH KOREA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 72 SOUTH KOREA SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 73 SOUTH KOREA SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 74 SOUTH KOREA RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 75 SOUTH KOREA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 76 SOUTH KOREA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 77 SOUTH KOREA RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 78 SOUTH KOREA RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 79 SOUTH KOREA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 80 NEW ZEALAND RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 81 NEW ZEALAND PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 82 NEW ZEALAND EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 83 NEW ZEALAND PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 84 NEW ZEALAND INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 85 NEW ZEALAND SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 86 NEW ZEALAND SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 87 NEW ZEALAND RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 88 NEW ZEALAND EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 89 NEW ZEALAND INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 90 NEW ZEALAND RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 91 NEW ZEALAND RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 92 NEW ZEALAND RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 93 SINGAPORE RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 94 SINGAPORE PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 95 SINGAPORE EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 96 SINGAPORE PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 97 SINGAPORE INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 98 SINGAPORE SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 99 SINGAPORE SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 100 SINGAPORE RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 101 SINGAPORE EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 102 SINGAPORE INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 103 SINGAPORE RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 104 SINGAPORE RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 105 SINGAPORE RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 106 THAILAND RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 107 THAILAND PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 108 THAILAND EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 109 THAILAND PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 110 THAILAND INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 111 THAILAND SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 112 THAILAND SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 113 THAILAND RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 114 THAILAND EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 115 THAILAND INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 116 THAILAND RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 117 THAILAND RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 118 THAILAND RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 119 MALAYSIA RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 120 MALAYSIA PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 121 MALAYSIA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 122 MALAYSIA PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 123 MALAYSIA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 124 MALAYSIA SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 125 MALAYSIA SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 126 MALAYSIA RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 127 MALAYSIA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 128 MALAYSIA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 129 MALAYSIA RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 130 MALAYSIA RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 131 MALAYSIA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 132 VIETNAM RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 133 VIETNAM PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 134 VIETNAM EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 135 VIETNAM PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 136 VIETNAM INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 137 VIETNAM SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 138 VIETNAM SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 139 VIETNAM RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 140 VIETNAM EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 141 VIETNAM INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 142 VIETNAM RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 143 VIETNAM RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 144 VIETNAM RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 145 TAIWAN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 146 TAIWAN PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 147 TAIWAN EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 148 TAIWAN PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 149 TAIWAN INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 150 TAIWAN SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 151 TAIWAN SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 152 TAIWAN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 153 TAIWAN EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 154 TAIWAN INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 155 TAIWAN RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 156 TAIWAN RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 157 TAIWAN RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 158 INDONESIA RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 159 INDONESIA PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 160 INDONESIA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 161 INDONESIA PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 162 INDONESIA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 163 INDONESIA SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 164 INDONESIA SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 165 INDONESIA RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 166 INDONESIA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 167 INDONESIA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 168 INDONESIA RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 169 INDONESIA RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 170 INDONESIA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 171 PHILIPPINES RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 172 PHILIPPINES PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 173 PHILIPPINES EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 174 PHILIPPINES PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 175 PHILIPPINES INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 176 PHILIPPINES SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 177 PHILIPPINES SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 178 PHILIPPINES RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 179 PHILIPPINES EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 180 PHILIPPINES INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 181 PHILIPPINES RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 182 PHILIPPINES RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 183 PHILIPPINES RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 184 REST OF ASIA-PACIFIC RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
그림 목록
FIGURE 1 ASIA-PACIFIC RADIOTHERAPY MARKET: SEGMENTATION
FIGURE 2 ASIA-PACIFIC RADIOTHERAPY MARKET: DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC RADIOTHERAPY MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC RADIOTHERAPY MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC RADIOTHERAPY MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC RADIOTHERAPY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA-PACIFIC RADIOTHERAPY MARKET: MARKET END USERS COVERAGE GRID
FIGURE 8 ASIA-PACIFIC RADIOTHERAPY MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASIA-PACIFIC RADIOTHERAPY MARKET: SEGMENTATION
FIGURE 10 THE GROWING PREVALANCE OF CANCER DISEASE AND NOVEL TECHNOLOGIES IN RADIOTHEAPY FOR CANCER TREATMENT ARE EXPECTED TO DRIVE THE GROWTH OF THE ASIA-PACIFIC RADIOTHERAPY MARKET FROM 2023 TO 2030
FIGURE 11 THE SERVICES SEGMENT, IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC RADIOTHERAPY MARKET IN 2023 & 2030
FIGURE 12 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA-PACIFIC RADIOTHERAPY MARKET
FIGURE 13 ASIA-PACIFIC RADIOTHERAPY MARKET: BY PRODUCT & SERVICES, 2022
FIGURE 14 ASIA-PACIFIC RADIOTHERAPY MARKET: BY PRODUCT & SERVICES, 2023-2030 (USD MILLION)
FIGURE 15 ASIA-PACIFIC RADIOTHERAPY MARKET: BY PRODUCT & SERVICES, CAGR (2023-2030)
FIGURE 16 ASIA-PACIFIC RADIOTHERAPY MARKET: BY PRODUCT & SERVICES, LIFELINE CURVE
FIGURE 17 ASIA-PACIFIC RADIOTHERAPY MARKET: BY TYPE, 2022
FIGURE 18 ASIA-PACIFIC RADIOTHERAPY MARKET: BY TYPE, 2023-2030 (USD MILLION)
FIGURE 19 ASIA-PACIFIC RADIOTHERAPY MARKET: BY TYPE, CAGR (2023-2030)
FIGURE 20 ASIA-PACIFIC RADIOTHERAPY MARKET: BY TYPE, LIFELINE CURVE
FIGURE 21 ASIA-PACIFIC RADIOTHERAPY MARKET: BY APPLICATION, 2022
FIGURE 22 ASIA-PACIFIC RADIOTHERAPY MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 23 ASIA-PACIFIC RADIOTHERAPY MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 24 ASIA-PACIFIC RADIOTHERAPY MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 25 ASIA-PACIFIC RADIOTHERAPY MARKET: BY END USER, 2022
FIGURE 26 ASIA-PACIFIC RADIOTHERAPY MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 27 ASIA-PACIFIC RADIOTHERAPY MARKET: BY END USER, CAGR (2023-2030)
FIGURE 28 ASIA-PACIFIC RADIOTHERAPY MARKET: BY END USER LIFELINE CURVE
FIGURE 29 ASIA-PACIFIC RADIOTHERAPY MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 30 ASIA-PACIFIC RADIOTHERAPY MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 31 ASIA-PACIFIC RADIOTHERAPY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 32 ASIA-PACIFIC RADIOTHERAPY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 33 ASIA-PACIFIC RADIOTHERAPY MARKET: BY SNAPSHOT (2022)
FIGURE 34 ASIA-PACIFIC RADIOTHERAPY MARKET: COMPANY SHARE 2022 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
